A2M 1H2022 earnings preview: Where next for A2M stock?

Its products are sold primarily in Australia, New Zealand, Greater China, and North America. A2M reports its half-year numbers on Monday, the 21st of February.

By its own admission, A2M has had an extraordinary journey, disrupted in FY 2021 by the arrival of COVID 19. Initially, A2M sales surged on a wave of panic buying, prompting A2M to upgrade its full-year earnings guidance in April 2020 by 32%.

Soon afterward, A2M experienced a drastic reversal of fortune, and the share price fell by over 75%. The closure of international borders bought the daigou/reseller channel to a halt that accounted for 60-70% of A2M’s revenue from Great China. And lower birth rates in China negatively impacted the size and growth of the China infant nutrition market.

The company has since acted to address the disruption, writing down excessive stock and bolstering its leadership team. Key to the companies turnaround will be building on its relatively small market share in China.

The company has long been touted as a takeover target. In August 2021, Nestle was reportedly taking a close look at A2M and, more recently, a rumour that Canadian dairy giant Saputo was a potential suitor. No bid has as yet has come from either rumours.

Analysts expect net profits after tax (NPAT) of NZ$60 million for 1HY22, a 50% reduction on the NZ$120 million of NPAT reported in 1HY21.

A2M Share Price Chart

After falling from a high of $20.05 in June 2021, the share price of A2M has settled into a range the past nine months, with support viewed near $5.00 and resistance viewed at $7.40ish.

Providing support at $5.00 holds another test of the $7.40 area is likely in the coming months, and as such, the bias is to be long A2M at current levels.

Source Tradingview. The figures stated areas of the 15th of February 2021. Past performance is not a reliable indicator of future performance. This report does not contain and is not to be taken as containing any financial product advice or financial product recommendation

How to trade with City Index

You can trade with City Index by following these four easy steps:

Open an account, or log in if you’re already a customer

• Open an account in the UK
• Open an account in Australia
• Open an account in Singapore
Search for the company you want to trade in our award-winning platform
Choose your position and size, and your stop and limit levels
Place the trade

From time to time, StoneX Financial Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.

City Index is a trading name of StoneX Financial Pty Ltd.

The material provided herein is general in nature and does not take into account your objectives, financial situation or needs.

While every care has been taken in preparing this material, we do not provide any representation or warranty (express or implied) with respect to its completeness or accuracy. This is not an invitation or an offer to invest nor is it a recommendation to buy or sell investments.

StoneX recommends you to seek independent financial and legal advice before making any financial investment decision. Trading CFDs and FX on margin carries a higher level of risk, and may not be suitable for all investors. The possibility exists that you could lose more than your initial investment further CFD investors do not own or have any rights to the underlying assets.

It is important you consider our Financial Services Guide and Product Disclosure Statement (PDS) available at www.cityindex.com/en-au/terms-and-policies/, before deciding to acquire or hold our products. As a part of our market risk management, we may take the opposite side of your trade. Our Target Market Determination (TMD) is also available at www.cityindex.com/en-au/terms-and-policies/.

StoneX Financial Pty Ltd, Suite 28.01, 264 George Street, Sydney, NSW 2000 (ACN 141 774 727, AFSL 345646) is the CFD issuer and our products are traded off exchange.